Daliresp and Weight loss - a phase IV clinical study of FDA data

Summary:

Weight loss is reported as a side effect among people who take Daliresp (roflumilast), especially for people who are female, 50-59 old, have been taking the drug for 1 - 2 years also take Symbicort, and have Narcolepsy.

The phase IV clinical study analyzes which people have Weight loss when taking Daliresp. It is created by eHealthMe based on reports of 4,674 people who have side effects when taking Daliresp from the FDA, and is updated regularly.

What is Daliresp?

Daliresp has active ingredients of roflumilast. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 4,722 Daliresp users. Check the latest studies of Daliresp.

What is Weight loss?

Weight loss is found to be associated with 1,442 drugs and 2,297 conditions by eHealthMe. Check the latest studies of Weight loss.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

4,674 people reported to have side effects when taking Daliresp.
Among them, 16 people (0.34%) have Weight loss.

Among these 16 people:

How long have people been on Daliresp when they have Weight loss? *

What is the gender of people who have Weight loss when taking Daliresp? *

female: 80 %
male: 20 %

What is the age of people who have Weight loss when taking Daliresp? *

What are other drugs people take besides Daliresp? *

Symbicort: 9 people, 56.25%
Zoloft: 7 people, 43.75%
Spiriva: 7 people, 43.75%
Lyrica: 7 people, 43.75%
Nuvigil: 6 people, 37.50%
Mirapex: 6 people, 37.50%
Ambien Cr: 6 people, 37.50%
Xyrem: 6 people, 37.50%
Vitamin D2: 6 people, 37.50%
Oxycodone And Acetaminophen: 6 people, 37.50%

What are other side effects people have besides Weight loss? *

Dyspnea (difficult or laboured breathing): 9 people, 56.25%
Abnormal Behavior: 6 people, 37.50%
High Blood Pressure: 5 people, 31.25%
Nausea (feeling of having an urge to vomit): 5 people, 31.25%
Chest Pain: 5 people, 31.25%
Weight Decreased: 4 people, 25.00%
Nausea And Vomiting: 4 people, 25.00%
Acute Respiratory Failure: 4 people, 25.00%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 3 people, 18.75%
Encephalopathy (functioning of the brain is affected by some agent or condition): 3 people, 18.75%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 37.50%
Wheezing (a high-pitched whistling sound made while you breath): 2 people, 12.50%
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 2 people, 12.50%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 12.50%
Pneumonia Pseudomonal (pseudomonas pneumonia is an infection caused by the microbe known as pseudomonas aeruginosa): 2 people, 12.50%
Drowsiness: 2 people, 12.50%
Dyspnea (difficult or laboured breathing): 1 person, 6.25%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 6.25%
Back Pain: 1 person, 6.25%
Bronchitis Chronic (inflammation of the mucous membrane in the bronchial tubes- chronic): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Daliresp and have Weight loss?

- Check whether Weight loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Daliresp:

Daliresp (4,722 reports)

Weight loss treatments and more:

Weight loss (62,432 reports)

Browse all side effects of Daliresp:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight loss:

Weight loss (1,442 drugs)

Browse all the conditions that are associated with Weight loss:

Weight loss (2,297 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on roflumilast (the active ingredients of Daliresp) and Daliresp (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.